Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001136261-16-000419
Filing Date
2016-03-10
Accepted
2016-03-10 09:43:02
Documents
113
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 10-K body10k.htm 10-K 1537197
2 SUBSIDIARIES exh21-1.htm EX-21.1 6249
3 CONSENT exh23-1.htm EX-23.1 1370
4 CEO 302 CERTIFICATE exh31-1.htm EX-31.1 5136
5 CFO 302 CERTIFICATE exh31-2.htm EX-31.2 4815
6 906 CERTIFICATE exh32-1.htm EX-32.1 3277
7 GRAPH graph.gif GRAPHIC 10236
8 LOGO image1904.jpg GRAPHIC 6415
  Complete submission text file 0001136261-16-000419.txt   7269731

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT ptx-20151231.xml EX-101.INS 1431746
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ptx-20151231.xsd EX-101.SCH 78363
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ptx-20151231_cal.xml EX-101.CAL 116997
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ptx-20151231_def.xml EX-101.DEF 160509
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ptx-20151231_lab.xml EX-101.LAB 577559
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ptx-20151231_pre.xml EX-101.PRE 401758
Mailing Address 10 NORTH PARK PLACE SUITE 201 MORRISTOWN NJ 07960
Business Address 10 NORTH PARK PLACE SUITE 201 MORRISTOWN NJ 07960 (862) 260-8457
PERNIX THERAPEUTICS HOLDINGS, INC. (Filer) CIK: 0001024126 (see all company filings)

EIN.: 330724736 | State of Incorp.: MD | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-14494 | Film No.: 161496394
SIC: 2834 Pharmaceutical Preparations